Electrochemical nanosensors for early detection of childhood cancer.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Early detection of childhood cancer is crucial for improving treatment outcomes. Identifying biomarkers for pediatric cancers is a critical step in cancer early detection and successful treatment. Biosensors are advanced analytical tools to identify cancer-related biomarkers with high sensitivity and specificity. Nanomaterials play a transformative role in the development of biosensors, enhancing their sensitivity, specificity, and overall performance. Nanomaterial based electrochemical sensors and biosensors as a cutting-edge frontier in analytical chemistry have enormous potential for detecting pediatric cancer biomarkers. By detecting biomarkers like proteins, DNA mutations, or metabolites associated with cancer, nano electrochemical biosensors offer a non-invasive, rapid, and affordable technique for early diagnosis, and disease monitoring.